Tag: MAT
Stimulant Activists to UN: Fund Agonist Research to End AIDS by 2030
In the final decade before the United Nations’ 2030 deadline to “end AIDS,” a ...
Telehealth Services Are Expanding OUD Medication Access—For Some
Amid the pandemic, regulatory changes around buprenorphine access are making it easier for some ...
When My Suboxone Doctor Quit on Me, It Left a Frightening Void
Early in 2020, shortly before pandemic entered the everyday lexicon and face masks became ...
Biden Is Opposing a Promising Step Toward Buprenorphine Deregulation
In the final week of former President Trump’s term, the US Department of Health ...
Coalition Demands Extra $15 Billion in Harm Reduction Funding From Biden Admin
A coalition of over 60 harm reduction organizations is calling for the Biden administration ...
Pharmacists May Be Key to Expanding Bupe Access, NIDA Pilot Shows
Collaboration between physicians and pharmacists may boost patients’ satisfaction with, and adherence to, buprenorphine ...
What Surging Fentanyl Use Among OAT Patients Says About the Pandemic
During the height of the COVID-19 lockdown in Ontario, Canada, the proportion of mandatory, ...
Two Roadmaps Show How New York Can Decriminalize Harm Reduction in 2021
Just a month following historic drug policy wins at the ballot box in November, ...
States Squander Opportunity of Billions of Dollars in Federal Treatment Grants
The overdose crisis is claiming a historic number of lives almost every year in ...
Where the Biden Administration Will Stand on Drugs and Harm Reduction
President-elect Joe Biden was a primary architect of the War on Drugs, with a ...
